menu
Search

Insights & Resources

In the ever-growing field of life sciences, it is important to always be learning. As frequent authors of industry-respected whitepapers and presenters at biopharma conventions, the practices of EVERSANA  CONSULTING are always working to stay at the forefront of this evolving field. Read some of our recent insights, case studies and other resources below.

Market Insights

Market Insights Case Study: Center of Excellence Profiling and Strategy

Client Situation Our client, an emerging oncology biotechnology company, was preparing to launch a key immuno-oncology asset that would be…

Read More

Market Insights Case Study: Due Diligence

Client Situation A rapidly growing specialty biopharma company was considering acquiring an in-line specialty drug indicated for a rare…

Read More

Product Commercialization

Product Commercialization Case Study: Launch Strategy and Plan for Emerging Biotech

Client Situation This small, public biotechnology company was approximately 24 months out from launching its first asset and had just hired…

Read More

Product Commercialization Case Study: Product Launch Planning and Strategy

Client Situation Our client, a leading pharmaceutical company, was 16 months from launching a central nervous system product with a novel…

Read More

Growth Maximization

Growth Maximization Case Study: Strategic Brand Planning

Client Situation Our client, a midsize biotech company, had launched its first oncologic in an increasingly crowded market and requested…

Read More

Growth Maximization Case Study: Ultra-Rare Orphan Drug Loss-of-Exclusivity Assessment and Strategy

Client Situation Our client was a global biopharma company that is a leader in the rare disease space. Leaders at the company sought an…

Read More

Pricing and Market Access

Pricing and Market Access Case Study: Medicaid Channel Strategy

Client Situation Due to changing market dynamics—namely, increasing competition and increasing payer management in an historically…

Read More

Pricing and Market Access Case Study: Organizational Benchmarking and Strategy

Client Situation Our client, a top-10 global pharmaceutical company, wanted to better understand how other leading biopharmaceutical…

Read More

Revenue Management & Finance Solutions

Pharmaceutical Contracting: From Volume to Value

White Paper Authored by Robert Blank, Revenue Management Team Driven by skyrocketing costs, market forces are hastening the shift in the…

Read More

More Data, More Problems, More Potential

In the November PM360 magazine feature, EVERSANA’s Robert Blank provides insight into the benefits of more data and the trends that…

Read More

Regulatory & Compliance Consulting

Solving the most complex regulatory challenges for combination therapies

Client Situation A small European biotechnology start-up company developing a novel approach in the treatment of major ophthalmic diseases…

Read More

Data Analytics

Building a Cloud-Based Data and Analytics Platform

Client Situation Like many small and midsize life science companies, this growing specialty-focused pharmaceutical company outsourced much…

Read More

Payer Influence Mapping: Integrating Strategy and Data Analytics

Client Situation A global biopharmaceutical company’s multi-indication therapeutic was poised to enter a new market crowded with…

Read More

White Papers

The Chronic Microcap Trap: How Launch Is The Escape For True Growth

Pre-commercial pharma companies face a common choice: commercialize products independently or collaborate with another pharmaceutical…

Read More

A Predictive Analytics and Machine Learning Approach to Improving Hub Performance and Patient Outcomes

  Today we have access to more data, from more sources than we could ever dream possible. Living in a digital world, we increasingly…

Read More

How Pharma Can Meet Commercialization and Marketing Challenges During COVID-19

With a resurgence of COVID-19 cases underway and a second wave of infections on the horizon, the health and economic threats the pandemic…

Read More

How to Maximize the Value of New Advances in Oncology

Cancer remains a global killer. Based on the most recent data recorded by the World Health Organization, globally there are about 14…

Read More

SELL’N GENE THERAPIES: A LANDSCAPE ASSESSMENT OF CELL AND GENE THERAPY REIMBURSEMENT

  Cell and gene therapies hold great life-saving potential, with the ability to treat disease states with significant morbidity,…

Read More

DON’T POKE THE BEAR: THE EFFECT OF PHARMACEUTICAL PRICING ON PERCEPTION AND FUTURE INNOVATION

Companies like Turing Pharmaceuticals and KV Pharmaceuticals have grabbed headlines recently for their aggressive pricing strategies.…

Read More

THE RADICAL IMPLICATIONS OF INDICATION-SPECIFIC PRICING

This paper discusses one of the potentially more impactful new dynamics in the pricing of pharmaceuticals—the advent of…

Read More

INTEGRATED DELIVERY NETWORKS

Learning to Engage With a New Customer With Very Different Needs As the healthcare provider landscape rapidly evolves to deliver on the…

Read More

Need advisors focused exclusively on the life sciences industry?

We can help you address strategic, tactical and operational concerns to increase value across your entire product lifecycle.

Contact